Inhibition of rheumatoid arthritis by blocking connective tissue growth factor

World Journal of Orthopedics

Volumn 5, Issue 5, 2014, Pages 653-659

  Nozawa, Kazuhisa ^a   Fujishiro, Maki ^b   Takasaki, Yoshinari ^a   Sekigawa, Iwao ^b,c  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Condrocytes; Connective tissue growth facto; Osteoclasts; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

EID: 84905966576     PISSN: None     EISSN: 22185836     Source Type: Journal    
DOI: 10.5312/wjo.v5.i5.653     Document Type: Article

References (18)

1. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440 [PMID: 8717520 DOI: 10.1146/annurev.immunol.14.1.397]
2. Fassbender HG, Seibel M, Hebert T. Pathways of destruction in metacarpal and metatarsal joints of patients with rheumatoid arthritis. Scand J Rheumatol 1992; 21: 10-16 [PMID: 1570480 DOI: 10.3109/03009749209095055]
3. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005; 115: 3318-3325 [PMID: 16322775 DOI: 10.1172/JCI27071]
4. Teitelbaum SL. Osteoclasts: what do they do and how do they do it? Am J Pathol 2007; 170: 427-435 [PMID: 17255310 DOI: 10.2353/ajpath.2007.060834]
5. Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev 1995; 144: 195-223 [PMID: 7590814 DOI: 10.1111/j.1600-065X.1995.tb00070.x]
6. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 2002; 110: 1419-1427 [PMID: 12438440 DOI: 10.1172/JCI0215582]
7. Sekigawa I, Yanagida M, Iwabuchi K, Kaneda K, Kaneko H, Takasaki Y, Jung G, Sone S, Tanaka Y, Ogawa H, Takamori K. Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy. Clin Exp Rheumatol 2008; 26: 261-267 [PMID: 18565247]
8. Nozawa K, Fujishiro M, Kawasaki M, Kaneko H, Iwabuchi K, Yanagida M, Suzuki F, Miyazawa K, Takasaki Y, Ogawa H, Takamori K, Sekigawa I. Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis. Arthritis Res Ther 2009; 11: R174 [PMID: 19922639 DOI: 10.1186/ar2863]
9. Nozawa K, Fujishiro M, Kawasaki M, Yamaguchi A, Ikeda K, Morimoto S, Iwabuchi K, Yanagida M, Ichinose S, Morioka M, Ogawa H, Takamori K, Takasaki Y, Sekigawa I. Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis. Arthritis Rheum 2013; 65: 1477-1486 [PMID: 23436223]
10. Fujishiro M, Yamaguchi A, Kawasaki M, Nozawa K, Takasaki Y, Takamori K, Ogawa H, Endo K, Ng PS, Takehara K, Sekigawa I. The detection of plasma levels of connective tissue growth factor in rheumatoid arthritis patients. Clin Exp Rheumatol 2012; 30: 145-146 [PMID: 22244584]
11. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991; 114: 1285-1294 [PMID: 1654338 DOI: 10.1083/jcb.114.6.1285]
12. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997; 8: 171-179 [PMID: 94622483 DOI: 10.1016/S1359-6101(97)00010-5]
13. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004; 363: 62-64 [PMID: 14723997 DOI: 10.1016/S0140-6736(03)15172-0]
14. Takigawa M, Nakanishi T, Kubota S, Nishida T. Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell Physiol 2003; 194: 256-266 [PMID: 12548546 DOI: 10.1002/jcp.10206]
15. Blaney Davidson EN, Vitters EL, Mooren FM, Oliver N, Berg WB, van der Kraan PM. Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. Arthritis Rheum 2006; 54: 1653-1661 [PMID: 16646035 DOI: 10.1002/art.21795]
16. Manns JM, Uknis AB, Rico MC, Agelan A, Castaneda J, Arango I, Barbe MF, Safadi FF, PopoffSN, DeLa Cadena RA. A peptide from thrombospondin 1 modulates experimental erosive arthritis by regulating connective tissue growth factor. Arthritis Rheum 2006; 54: 2415-2422 [PMID: 16869004 DOI: 10.1002/art.22021]
17. Cooker LA, Peterson D, Rambow J, Riser ML, Riser RE, Najmabadi F, Brigstock D, Riser BL. TNF-alpha, but not IFNgamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. Am J Physiol Renal Physiol 2007; 293: F157-F165 [PMID: 17376761 DOI: 10.1152/ajprenal.00508.2006]
18. Laug R, Fehrholz M, Schütze N, Kramer BW, Krump- Konvalinkova V, Speer CP, Kunzmann S. IFN-γ and TNF-α synergize to inhibit CTGF expression in human lung endothelial cells. PLoS One 2012; 7: e45430 [PMID: 23029004 DOI: 10.1371/journal.pone.0045430]